TDP1 is a promising molecular target in cancer therapy because it participates in the repair of many DNA adducts formed by chemotherapeutic drugs such as topotecan, etoposide, bleomycin, temozolomide [2,3]. The gene discussed is TDP1; the disease is cancer.